REG - Anpario PLC - AGM Statement

AnparioAnnouncement

19/06/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250619:nRSS4973Na&default-theme=true

RNS Number : 4973N  Anpario PLC  19 June 2025

Anpario plc
("Anpario", "Group" or the "Company")

 

AGM Statement

 

 

Anpario plc, the independent manufacturer of natural sustainable animal feed
additives for health, nutrition and biosecurity, is holding its AGM later
today, at which Matthew Robinson, Chairman, will make the following statement:

 

"The Group achieved a strong sales performance in the first half of the year
as our business development initiatives deliver and the global agriculture
market improves.  As such, we are confident of achieving market expectations*
for the full year. There are challenges to navigate, however, and the current
geopolitical environment makes it difficult to predict if and how our markets
could be affected, but our geographic, species and product diversity should
help to mitigate against any potential adverse impact.

 

We are particularly encouraged by a strong performance in the United States
with a recovery in the sales of pHorce® to the swine sector and continued
growth of Orego-Stim® in the organic egg layer and young cattle segments.
India is also delivering a particularly strong performance.  Brazil continues
to disappoint due to tough local trading conditions.

 

The Group's business development initiatives include preparation to launch
several Bio-Vet products, including leading brands RumenAider®, Generator™
and QuadriCal®, in various territories around the world.  Initial
discussions with customers and Anpario's global sales team are very
encouraging and product registration work is now underway.

 

Following a strong end to 2024, we have been normalising our inventory levels
to support the higher levels of activity seen at the end of last year and the
continued growth in 2025. At the same time, we have seen a proportional
increase in trade receivables which has absorbed further cash as well as a
reduction in trade and other payables, leading to a slight reduction in
overall cash. Our cash balance was £9.0m as at 31 May 2025 (£10.5m at 31
December 2024), representing a strong financial position with which to
continue to grow the business, both organically and through acquisitions,
should the right opportunities arise."

 

The Company's interim results for the six months period ended 30 June 2025 are
expected to be announced on 10 September 2025.

 

 

*Analyst consensus for FY 2025 immediately prior to this announcement was
Revenue of £44.8m, EBITDA of £7.6m and net cash of £11.9m.

 

 

 

Enquiries

 

 Anpario plc
 Richard Edwards, Chief Executive Officer  +44(0)7776 417 129
 Marc Wilson, Group Finance Director       +44(0)1909 537 380

 Shore Capital
 (Nominated Adviser and Broker)            +44 (0) 20 7408 4090
 Stephane Auton                            Corporate Advisory
 David Coaten
 Tom Knibbs
 Henry Willcocks                           Corporate Broking

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGMFFFSVRLITLIE